Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 10Recruiting 5Active not recruiting 3Withdrawn 2Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Melanoma 3Carcinoma, Non-Small-Cell Lung 3Colorectal Neoplasms 2Carcinoma, Renal Cell 2Uveal Melanoma 1Turcot syndrome 1Sarcoma 1Post-Acute COVID-19 Syndrome 1Pancreatic Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Fibrolamellar hepatocellular carcinoma 1Clear-cell metastatic renal cell carcinoma 1Carcinoma 1Advanced Kidney Cancer 1

Interventions

Bevacizumab 37Oxaliplatin 17Capecitabine 17Irinotecan 15Leucovorin 13HMPL-013 12Fluorouracil 12Cetuximab 11trifluridine tipiracil drug combination 7irinotecan sucrosofate 6tipiracil 5Trifluridine 5Specimen Handling 5Drug Therapy 5tislelizumab 4Standard of Care 4Mitomycin 4Magnetic Resonance Spectroscopy 4Injections 4Folfox protocol 4trametinib 3toripalimab 3pembrolizumab 3Nivolumab 3IFL protocol 3Colonoscopy 3Blood Specimen Collection 3Biopsy 3sotorasib 2sintilimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Colorectal Neoplasms × Ipilimumab × Clear all
NCT07587827 2026-05-14

ODI-2001-01

Centre Georges Francois Leclerc

Phase 1 Not yet recruiting
77 enrolled
Gastrointestinal

Pancreatic Neoplasms, Colorectal Neoplasms

NCT07403877 2026-02-11

TORCH-OPTIMA

Fudan University

Phase 2 Not yet recruiting
114 enrolled
Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡